Veeva’s latest report, The State of Data, Analytics, and AI in Commercial Biopharma, revealed a critical industry paradox: ...

The Autumn Budget, with its £26 billion tax rise by 2029-30, will “drive an exodus of wealth from Britain,” warned Nigel ...

Digital health and digital therapeutics have been around for a long time now. But when will we really start to realise the ...

Novo Nordisk is filing its supplemental new drug application (sNDA) for Wegovy 7.2 mg on the back of the phase 3b STEP UP ...

Sanofi is being probed for 'money laundering of tax fraud', 'money laundering of tax fraud by an organised or aggravated ...

Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has ...

Prenuvo CEO Andrew Lacy sat down with pharmaphorum after their Frontiers Health keynote to discuss: ...

Anti-APRIL antibody Voyxact (sibeprenlimab) has been approved by the US regulator to reduce proteinuria in adults with ...

This video captures the essence of a very special 10th Anniversary Frontiers Health - visionary talks, groundbreaking ...

When applied responsibly, AI empowers medical, commercial, and access teams to make faster, evidence-based decisions and ...

Digital health is now an essential tool to scaling healthcare, but there are still many challenges to deploying it scalably ...

Novo Nordisk said it will now move ahead with a phase 3 programme for both versions of the drug in adults with type 2 ...